Literature DB >> 18271526

Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.

Jiefei Tong1, Paul Taylor, Eleonora Jovceva, Jonathan R St-Germain, Lily L Jin, Ana Nikolic, Xiaoping Gu, Zhi Hua Li, Suzanne Trudel, Michael F Moran.   

Abstract

To identify phosphotyrosine (pY) sites in the epidermal growth factor receptor (EGFR) network, a tandem immunoprecipitation-mass spectrometry method (TIPY-MS) was applied wherein protease-digested EGFR immune complexes were extracted with anti-pY after Rush et al. ( Nat. Biotech. 2005, 23, 94 ) and analyzed by LC-MS/MS. New pY sites in the pathway were found, including SOS1 Y1065, SOS2 Y1275, CBL-B Y889, and in the EGFR regulatory protein Mig-6 Y458. The novel human C19orf19 gene product was found EGFR-associated and phosphorylated at 5 tyrosines in response to EGFR activation and, therefore, represents a new component of the EGFR signaling network.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18271526     DOI: 10.1021/pr7006363

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  13 in total

1.  In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling.

Authors:  Paul J Boersema; Leong Yan Foong; Vanessa M Y Ding; Simone Lemeer; Bas van Breukelen; Robin Philp; Jos Boekhorst; Berend Snel; Jeroen den Hertog; Andre B H Choo; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2009-09-21       Impact factor: 5.911

2.  The Epidermal Growth Factor Receptor Forms Location-Dependent Complexes in Resting Cells.

Authors:  Sibel Yavas; Radek Macháň; Thorsten Wohland
Journal:  Biophys J       Date:  2016-11-15       Impact factor: 4.033

3.  Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling.

Authors:  Ning Liu; Masaki Matsumoto; Kyoko Kitagawa; Yojiro Kotake; Sayuri Suzuki; Senji Shirasawa; Keiichi I Nakayama; Makoto Nakanishi; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  EMBO J       Date:  2012-04-13       Impact factor: 11.598

4.  Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.

Authors:  Jiefei Tong; Paul Taylor; Michael F Moran
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

5.  Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.

Authors:  Guolin Zhang; Bin Fang; Richard Z Liu; Huiyi Lin; Fumi Kinose; Yun Bai; Umut Oguz; Elizabeth R Remily-Wood; Jiannong Li; Soner Altiok; Steven Eschrich; John Koomen; Eric B Haura
Journal:  J Proteome Res       Date:  2010-12-03       Impact factor: 4.466

6.  Odin (ANKS1A) modulates EGF receptor recycling and stability.

Authors:  Jiefei Tong; Yaroslav Sydorskyy; Jonathan R St-Germain; Paul Taylor; Ming S Tsao; Michael F Moran
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

7.  LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.

Authors:  Ruth Milkereit; Avinash Persaud; Liviu Vanoaica; Adriano Guetg; Francois Verrey; Daniela Rotin
Journal:  Nat Commun       Date:  2015-05-22       Impact factor: 14.919

8.  Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.

Authors:  Jiefei Tong; Paul Taylor; Scott M Peterman; Amol Prakash; Michael F Moran
Journal:  Mol Cell Proteomics       Date:  2009-06-15       Impact factor: 5.911

9.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

10.  The ShcD signaling adaptor facilitates ligand-independent phosphorylation of the EGF receptor.

Authors:  Melanie K B Wills; Jiefei Tong; Sylvie L Tremblay; Michael F Moran; Nina Jones
Journal:  Mol Biol Cell       Date:  2014-01-15       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.